Quanterix, a company developing technology designed to enable earlier disease detection, made its market debut on Thursday. Shares of the company surged after pricing at $15 a share, and opening at $16.25 a share. Kevin Hrusovsky, CEO of Quanterix, was with us to discuss how the company plans to revolutionize healthcare. The fourth-leading cause of death is drug side effects, and drugs only work half the time, says Hrusovsky. He believes that if you can personalize the drugs, you have an opportunity to improve the whole pharmaceutical industry. Quanterix is developing technology that will digitize how they see into blood, and help to see disease long before there are symptoms. Rocket science is being deployed into the blood, says Hrusovsky. He says that if you can see biomarkers and incorporate into fitbits, it can really help improve health.

Share:
More In Science
Why The American West Is Running Out Of Water
Millions of people thrive in the American West’s deserts today, but not every is thriving. You’ve probably heard of droughts and wildfires in California, of groundwater drying up in Arizona, and of entire communities, like those on the Navajo Nation, that have been left without running water. The region is finally coming to terms with decades of infrastructure projects, coupled with using more water than nature can provide, as the threat of climate change moves in. Cheddar explains why the American West is running out of water.
Load More